Literature DB >> 4400573

Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

M E Conolly, D S Davies, C T Dollery, C F George.   

Abstract

1. Resistance to isoprenaline has been produced in man and dog by prolonged exposure to the same, or the pharmacologically similar compounds, terbutaline and isoetharine.2. In guinea-pigs, pretreatment with these agents increases asthma mortality provoked by histamine which suggests that this resistance may reduce the effectiveness of endogenous sympathetic drive to the bronchi.3. Possible mechanisms by which the asthma death rate could be increased are discussed.4. It is suggested that a drug-induced cross resistance to endogenous sympathetic stimulation could have led to a deterioration of the asthmatic state in patients using the pressurized aerosols of sympathomimetic bronchodilators and that this might account for the rise in asthma death rate.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4400573      PMCID: PMC1665912     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Isoprenaline resistance and the use of pressurised aerosols in asthma.

Authors:  J W Paterson; M E Conolly; D S Davies; C T Dollery
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

2.  Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols.

Authors:  W H Inman; A M Adelstein
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

3.  The metabolic fate of DL(7-3H)isoprenaline in man and dog.

Authors:  C D Morgan; M Sandler; D S Davies; M Conolly; J W Paterson; C T Dollery
Journal:  Biochem J       Date:  1969-08       Impact factor: 3.857

4.  The effects of posture, oxygen, isoproterenol and atropine on ventilation-perfusion relationships in the lung in asthma.

Authors:  G B Field
Journal:  Clin Sci       Date:  1967-04       Impact factor: 6.124

5.  Death in asthmatics.

Authors:  T E Van Metre
Journal:  Trans Am Clin Climatol Assoc       Date:  1967

6.  The J. Burns Amberson Lecture. The management of acute respiratory failure in chronic bronchitis and emphysema.

Authors:  E J Campbell
Journal:  Am Rev Respir Dis       Date:  1967-10

7.  Effect of propranolol on ventilatory function.

Authors:  R S McNeill; C G Ingram
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

8.  Iatrogenic asthma associated with adrenergic aerosols.

Authors:  J F Keighley
Journal:  Ann Intern Med       Date:  1966-11       Impact factor: 25.391

9.  Response of blood gas tensions to aminophylline and isoprenaline in patients with asthma.

Authors:  E Tai; J Read
Journal:  Thorax       Date:  1967-11       Impact factor: 9.139

10.  The cardio-toxicity of isoprenaline during hypoxia.

Authors:  J M Collins; D G McDevitt; R G Shanks; J G Swanton
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

View more
  59 in total

1.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

2.  Metabolic effects of oral salbutamol in late pregnancy.

Authors:  N O Lunell; J Wager; B B Fredholm; B Persson
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

3.  Proceedings: Alterations to vasodilator effects of isoprenaline in the dog following intra-arterial infusions with isoprenaline, salbutamol and orciprenaline.

Authors:  P S Collier; R G Shanks
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

4.  Comparison of intravenous ibuterol (KWD 2058), a new bronchodilator, and terbutaline.

Authors:  S Larsson; N Svedmyr
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953

5.  Intravenous treatment with rimiterol and salbutamol in asthma.

Authors:  G E Marlin; P Turner
Journal:  Br Med J       Date:  1975-06-28

6.  Lack of cardiac or bronchodilator tachyphylaxis to isoprenaline in the dog.

Authors:  H Minatoya; B A Spilker
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

7.  Desensitization of the beta-adrenoceptor of lymphocytes from normal subjects and asthmatic patients in vitro.

Authors:  J K Greenacre; P Schofield; M E Conolly
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

8.  Metabolism of isoprenaline in dog and man.

Authors:  M E Conolly; D S Davies; C T Dollery; C D Morgan; J W Paterson; M Sandler
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

9.  Supersensitivity of salivation in response to pilocarpine after withdrawal of chronically administered hyoscine in the mouse.

Authors:  M W Parkes; J C Parks
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

10.  Circulatory effects of oral and subcutaneous administration in normal subjects of a new bronchodilator, ibuterol, a pro-drug to terbutaline.

Authors:  E Höglund; H Westling; T White
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.